Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cell. 2012 May 11;149(4):735-7. doi: 10.1016/j.cell.2012.04.015.

EGFR in limbo.

Author information

  • 1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. eck@red.dfci.harvard.edu

Abstract

The epidermal growth factor receptor (EGFR) is normally activated by ligand-induced dimerization. Oncogenic mutations in EGFR promote activation in a largely ligand-independent manner. Shan et al. uncover a partially disordered state of EGFR kinase, providing evidence that oncogenic mutations counteract this intrinsic structural instability to promote dimerization and aberrant activation.

Copyright © 2012 Elsevier Inc. All rights reserved.

Comment on

PMID:
22579278
[PubMed]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk